Size a factor in maternity ward complaints

Smaller is not better when it comes to maternity wards, according to study results that for the first time link mother and child safety with maternity ward size.

he study, carried out by Copenhagen hospital Rigshopitalet and the patient insurance organisation Patientforsikringen, which rules in complaints of health service malpractice, found that half of complaints lodged against wards with under 1,000 births a year were upheld.

Larger wards, with up to 3,000 births a year, had one of three complaints against them upheld. 

Politiken 

SEE RELATED: Hospital denied woman who didn't call ahead

This story was included in The Copenhagen Post's Morning Briefing for Monday, September 16. If you would like to receive stories like these delivered to your inbox by 8am each weekday, sign up for the Morning Briefing or one of our other newsletters today. 





  • How internationals can benefit from joining trade unions

    How internationals can benefit from joining trade unions

    Being part of a trade union is a long-established norm for Danes. But many internationals do not join unions – instead enduring workers’ rights violations. Find out how joining a union could benefit you, and how to go about it.

  • Internationals in Denmark rarely join a trade union

    Internationals in Denmark rarely join a trade union

    Internationals are overrepresented in the lowest-paid fields of agriculture, transport, cleaning, hotels and restaurants, and construction – industries that classically lack collective agreements. A new analysis from the Workers’ Union’s Business Council suggests that internationals rarely join trade unions – but if they did, it would generate better industry standards.

  • Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    The numbers are especially striking amongst the 3,477 business and economics students polled, of whom 31 percent elected Novo Nordisk as their favorite, compared with 20 percent last year.